What Researchers Did
This study compared the effects of hyperbaric oxygen therapy administered once or twice daily, combined with naftidrofuryl, for sudden deafness.
What They Found
Researchers found that the efficiency and side effects of hyperbaric oxygen therapy were similar between the two groups receiving either one or two sessions per day. This was observed when combined with naftidrofuryl and steroids, and after preliminary normovolemic hemodilution.
What This Means for Canadian Patients
For Canadian patients experiencing sudden deafness, this study suggests that hyperbaric oxygen therapy administered once a day may be as effective as twice a day. However, the twice-daily regimen, while potentially advantageous for health policy, requires hospitalization and may be more suitable for younger individuals.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in a different healthcare context.
Study Limitations
A key limitation is the unknown origin and spontaneous recovery rate of sudden deafness, making it difficult to definitively claim treatment efficiency.